MIR497HG‐Derived miR‐195 and miR‐497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer

Tamoxifen is commonly used for the treatment of patients with estrogen receptor‐positive (ER+) breast cancer, but the acquired resistance to tamoxifen presents a critical challenge of breast cancer therapeutics. Recently, long noncoding RNA MIR497HG and its embedded miR‐497 and miR‐195 are proved to...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yao, Chen, Zhao‐Hui, Wu, Peng, Zhang, Di, Ma, Yue, Liu, Xiao‐Feng, Wang, Xin, Ding, Dan, Cao, Xu‐Chen, Yu, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131819/
https://www.ncbi.nlm.nih.gov/pubmed/36815359
http://dx.doi.org/10.1002/advs.202204819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131819/
https://www.ncbi.nlm.nih.gov/pubmed/36815359
http://dx.doi.org/10.1002/advs.202204819

Ejemplares similares